Osemitamab is an IgG1 antibody targeting to human claudin-18.2. Osemitamab consists of human-Mus musculus monoclonal TST001 gamma1-chain, disulfide with human-Mus musculus monoclonal TST001 kappa-chain, dimer (ACI). Osemitamab in combination with Capecitabine (HY-B0016) and Oxaliplatin (HY-17371), can be used for G/GEJ cancer study[1][2].
Molecular Weight:
(146.5 kDa)
Purity:
99.43
CAS Number:
[2460539-61-9]
Target:
Gap Junction Protein
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted